SCHEMBL23926002

SCHEMBL23926002

C=C(CCCC)COCCC#N

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
CES2 O00748 1/20 0.32
ZDHHC20 Q5W0Z9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23925768 0.95 TSHR (0.39) TSHRCES2ZDHHC20
SCHEMBL28977808 0.93 TSHR (0.38) TSHRCES2ZDHHC20
SCHEMBL28977789 0.89 TSHR (0.33) TSHR
SCHEMBL28977811 0.81 TSHR (0.31) TSHR
SCHEMBL23925686 0.77 ALDH1A1 (0.38)
SCHEMBL11501633 0.72
SCHEMBL1246944 0.72
SCHEMBL11805582 0.72 CES2 (0.40) TSHRCES2
SCHEMBL25167302 0.71
SCHEMBL28977807 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4136067-B1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H KELKAR AND COMPANY LTD (IN) 2026-04-15 EP claimed
US-12522780-B2 Odorants and compositions comprising odorants S H KELKAR AND COMPANY LIMITED (IN) 2026-01-13 US claimed
US-20230141482-A1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H KELKAR & COMPANY LIMITED (IN) 2023-05-11 US claimed
EP-4136067-A1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H Kelkar and Company Limited (IN) 2023-02-22 EP claimed
CN-115551829-A Odorants and compositions comprising odorants 丝趣科尔卡有限公司 2022-12-30 CN claimed
WO-2021209944-A1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H KELKAR AND COMPANY LIMITED (IN) 2021-10-21 WO claimed
EP-4136067-B1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H KELKAR AND COMPANY LTD (IN) 2026-04-15 EP disclosed
US-12522780-B2 Odorants and compositions comprising odorants S H KELKAR AND COMPANY LIMITED (IN) 2026-01-13 US disclosed
US-20230141482-A1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H KELKAR & COMPANY LIMITED (IN) 2023-05-11 US disclosed
EP-4136067-A1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H Kelkar and Company Limited (IN) 2023-02-22 EP disclosed
CN-115551829-A Odorants and compositions comprising odorants 丝趣科尔卡有限公司 2022-12-30 CN disclosed
WO-2021209944-A1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H KELKAR AND COMPANY LIMITED (IN) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230141482-A1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS CDY1; CDY1B, ACMSD, ADH5 TSHR 4551/4885CES2 770/4885ZDHHC20 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.